MIAMI, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (LGVN) (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and ...
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY) and a cutting-edge innovator at the intersection of AI, clinical ...
Membership comes in recognition of Dr. Anderson’s contributions to optical quantum engineering of ultracold atoms Infleqtion, a global leader in quantum sensing and quantum computing, develops ...
Gallagher Re’s Chief Science Officer, Steve Bowen, has noted that while weather and climate factors are certainly part of the ...
The Prostate Cancer Foundation (PCF) today announced that Howard R. Soule, Ph.D., will retire as PCF’s Chief Science Officer, Executive Vice President, and Lori and Michael Milken Chair at the end of ...
Hosted on MSN
Peter Attia steps down from chief science officer role at David Protein amid Epstein files row
Peter Rahal, the CEO of David Protein, has announced that Dr. Peter Attia has stepped down from his role as Chief Science Officer at the company. This comes after reports that Attia, an influential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results